What is Gynesonics about? How are you changing the standard of care in uterine fibroids? Gynesonics is focused on advancing women’s health by developing uterus-preserving, incision free, transcervical technology. Currently, we are focused on the treatment of symptomatic uterine fibroids, a condition that affects up to 50% of women [...]
Boston Scientific Announces Agreement to Acquire Vertiflex, Inc. Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies. Vertiflex has raised approximately $160 million in funding from investors including Endeavour Vision, NEA and H.I.G. BioVentures. MARLBOROUGH, Mass., May 9, 2019 / — Boston Scientific (NYSE: [...]
Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies. Novel program provides reimbursement for TLD therapy in France MINNEAPOLIS, April 28, 2018 – Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, has received acceptance from the Haute Autorité de Santé (HAS, the [...]
Intracept® Procedure Demonstrates Durable Results at 24 Months. MINNEAPOLIS – April 24, 2019 – Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced the publication of 24-month results from the SMART trial in the International Journal of Spine Surgery. A [...]
for its Solid Tumor Solution for accurate cancer detection. Lausanne, SWITZERLAND – 11 April 2019: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the CE-IVD marking of its Solid Tumor Solution (STS), a new step in the fight against cancer. This standardized molecular diagnostic application precisely detects and [...]
William T. Abraham, Md Joins V-wave as Chief Medical Officer CAESAREA, Israel, March 11, 2019 – V-Wave Ltd., an early stage medtech company, developing an implantable interatrial shunt device for treating advanced heart failure (HF) and pulmonary arterial hypertension (PAH), announced today that renowned heart failure cardiologist, William [...]
Redwood City, CA – March 5, 2019 – Gynesonics, a women’s healthcare company and the developer of the Sonata® system for the treatment of uterine fibroids (also known as leiomyomas) today announced the publication of the VITALITY study in the Journal of Gynecologic Surgery. The article, “Long-Term Clinical Outcomes [...]
MINNEAPOLIS, Feb. 11, 2019 /PRNewswire/ — Nuvaira, a developer of novel therapeutic medical devices to treat obstructive lung diseases, announced today it has closed a $79 million equity financing led by U.S. Venture Partners, with Endeavour Vision, Qiming Venture Partners, Lightstone Ventures and Richard King Mellon Foundation joining the [...]
Intracept® Procedure Demonstrates Highly Significant Treatment Effect vs. Non-Surgical Management MINNEAPOLIS – January 30, 2019 – Relievant Medsystems, a privately‐held medical device company, developing minimally‐invasive solutions for chronic low back pain (CLBP), today announced that a pre‐specified interim analysis of the Level I INTRACEPT Randomized Controlled Trial (RCT) found [...]
Redwood City, CA – January 10, 2019 – Gynesonics, a women’s healthcare company and the developer of the Sonata® system for the treatment of uterine fibroids (also known as leiomyomas) today announced the publication of the SONATA IDE Pivotal Trial 12-month results in the January edition of Obstetrics and [...]